Table 2.
Perceived benefits (total mean score) | Perceived burdens (total mean score) | HbA1c (mean) | ||||
---|---|---|---|---|---|---|
Gender | ||||||
Male | 4.19 | P = .822 | 1.99 | P = .773 | 8.7% | P = .411 |
Female | 4.18 | 1.97 | 8.6% | |||
CGM use | ||||||
CGM use | 4.48 | P < .001 | 1.69 | P < .001 | 8.1% | P < .001 |
Non-CGM user | 4.19 | 2.35 | 9.1% | |||
Insulin pump | ||||||
Pump use | 4.26 | P < .001 | 1.89 | P < .001 | 8.5% | P < .003 |
MDI | 4.03 | 2.16 | 8.8% |
Mean score scale one to five: one is strongly disagree and five is strongly agree.
The higher the mean score, the greater the benefit or burden.
CGM, continuous glucose monitoring; HbA1c, glycated hemoglobin; MDI, multiple daily insulin injections.